Breast cancer, one of the most common cancers in women, has various treatment modalities. Neoadjuvant therapy (NAT) has been used in many clinical trials because it is easy to evaluate the treatment response to therapeutic agents in a short time period; consequently, NAT is currently a standard treatment modality for large-sized and locally advanced breast cancers, and its use in early-stage breast cancer is becoming more common. Thus, chances to encounter breast tissue from patients treated with NAT is increasing. However, systems for handling and evaluating such specimens have not been established. Several evaluation systems emphasize a multidisciplinary approach to increase the accuracy of breast cancer assessment. Thus, detailed and systematic evaluation of clinical, radiologic, and pathologic findings is important. In this review, we compare the major problems of each evaluation system and discuss important points for handling and evaluating NAT-treated breast specimens.
Citations
Citations to this article as recorded by
Evaluating the Tumor Burden, Histological Changes, and Immune Landscape of Breast Cancer Post-neoadjuvant Chemotherapy: Insights From 50 Cases Arasi Rajesh, Dharma Saranya Gurusamy, Rajalakshmi Manikkam Cureus.2025;[Epub] CrossRef
Good practice: The experiences with the utilization of residual cancer burden—A single institution study Anita Sejben, Fanni Hegedűs, Szintia Almási, Márton Berta, Orsolya Oláh‐Németh, Tamás Zombori Thoracic Cancer.2023; 14(11): 963. CrossRef
Assessing the Correlation of Rate of Pathological Complete Response and Outcome in Post Neoadjuvant Chemotherapy Setting and Molecular Subtypes of Breast Cancer Ahmad Omair, Abdulmohsen Alkushi, Ghaida Alamri, Talal Almojel, Sara Alsadun, Emad Masuadi, Haitham Arabi, Amin E Mohamed, Omalkhair A Abulkhair Cureus.2023;[Epub] CrossRef
Compression OCT-elastography combined with speckle-contrast analysis as an approach to the morphological assessment of breast cancer tissue Anton A. Plekhanov, Ekaterina V. Gubarkova, Marina A. Sirotkina, Alexander A. Sovetsky, Dmitry A. Vorontsov, Lev A. Matveev, Sergey S. Kuznetsov, Alexandra Y. Bogomolova, Alexey Y. Vorontsov, Alexander L. Matveyev, Sergey V. Gamayunov, Elena V. Zagaynova, Biomedical Optics Express.2023; 14(6): 3037. CrossRef
Ambiguity-aware breast tumor cellularity estimation via self-ensemble label distribution learning Xiangyu Li, Xinjie Liang, Gongning Luo, Wei Wang, Kuanquan Wang, Shuo Li Medical Image Analysis.2023; 90: 102944. CrossRef
Concurrent Chemo-radiation As a Means of Achieving Pathologic Complete Response in Triple Negative Breast Cancer Maryam Nemati Shafaee, Shalini Makawita, Bora Lim, Matthew J Ellis, Michelle S Ludwig Clinical Breast Cancer.2022; 22(4): e536. CrossRef
Pathology after neoadjuvant treatment – How to assess residual disease Giuseppe Viale, Nicola Fusco The Breast.2022; 62: S25. CrossRef
Efficacy Evaluation of Neoadjuvant Chemotherapy in Breast Cancer by MRI Yongguang Liu, Mingxiang Wu, Wenyong Tan, Jingshan Gong, Jie Ma, Mohammad Farukh Hashmi Contrast Media & Molecular Imaging.2022;[Epub] CrossRef
Predictive Role of Soluble IL-6R, TNF-R1/2, and Cell Adhesion Molecules Serum Levels in the Preoperative and Adjuvant Therapy in Women with Nonmetastatic Breast Cancer: A Preliminary Study Weronika Bulska-Będkowska, Paulina Czajka-Francuz, Sylwia Cisoń-Jurek, Aleksander J. Owczarek, Tomasz Francuz, Jerzy Chudek Journal of Interferon & Cytokine Research.2022; 42(11): 557. CrossRef
The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis Jinzhao Liu, Yifei Li, Weifang Zhang, Chenhui Yang, Chao Yang, Liang Chen, Mingjian Ding, Liang Zhang, Xiaojun Liu, Guozhong Cui, Yunjiang Liu Frontiers in Surgery.2022;[Epub] CrossRef
The Role of miR-375-3p, miR-210-3p and Let-7e-5p in the Pathological Response of Breast Cancer Patients to Neoadjuvant Therapy Lorena Alexandra Lisencu, Andrei Roman, Simona Visan, Eduard-Alexandru Bonci, Andrei Pașca, Emilia Grigorescu, Elena Mustea, Andrei Cismaru, Alexandru Irimie, Cosmin Lisencu, Loredana Balacescu, Ovidiu Balacescu, Oana Tudoran Medicina.2022; 58(10): 1494. CrossRef
Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer Elisa Agostinetto, Flavia Jacobs, Véronique Debien, Alex De Caluwé, Catalin-Florin Pop, Xavier Catteau, Philippe Aftimos, Evandro de Azambuja, Laurence Buisseret Cancers.2022; 14(21): 5467. CrossRef
Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment Joshua J. Li, Julia Y. Tsang, Gary M. Tse Cancers.2021; 13(16): 4233. CrossRef
SPIE-AAPM-NCI BreastPathQ challenge: an image analysis challenge for quantitative tumor cellularity assessment in breast cancer histology images following neoadjuvant treatment Nicholas Petrick, Shazia Akbar, Kenny H. Cha, Sharon Nofech-Mozes, Berkman Sahiner, Marios A. Gavrielides, Jayashree Kalpathy-Cramer, Karen Drukker, Anne L. Martel, for the BreastPathQ Challenge Group Journal of Medical Imaging.2021;[Epub] CrossRef
Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography Ryusuke Murakami, Hitomi Tani, Shinichiro Kumita, Nachiko Uchiyama Acta Radiologica Open.2021;[Epub] CrossRef
Los márgenes Laia Bernet, María Angeles Montero Fernández Revista de Senología y Patología Mamaria.2021; 34: S25. CrossRef
Neoadjuvant chemotherapy in non‐metastatic breast cancer: a study on practice trends in a regional cancer treatment service Edmond Ang, Navin Wewala, Rebecca Carroll, Garry Forgeson, Malcolm Anderson, Jennifer Fernando, Jody Jordan, Richard Isaacs Internal Medicine Journal.2020; 50(3): 315. CrossRef
Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy Anita Sejben, Renáta Kószó, Zsuzsanna Kahán, Gábor Cserni, Tamás Zombori Pathology & Oncology Research.2020; 26(4): 2747. CrossRef
Integrating evolutionary dynamics into cancer therapy Robert A. Gatenby, Joel S. Brown Nature Reviews Clinical Oncology.2020; 17(11): 675. CrossRef
Assessing the accuracy of conventional gadolinium‐enhanced breast MRI in measuring the nodal response to neoadjuvant chemotherapy (NAC) in breast cancer Lisa Christine Murphy, Edel Marie Quinn, Zeeshan Razzaq, Claire Brady, Vicki Livingstone, Lorna Duddy, Josephine Barry, Henry Paul Redmond, Mark Anthony Corrigan The Breast Journal.2020; 26(11): 2151. CrossRef
Early prediction of neoadjuvant chemotherapy response for advanced breast cancer using PET/MRI image deep learning Joon Ho Choi, Hyun-Ah Kim, Wook Kim, Ilhan Lim, Inki Lee, Byung Hyun Byun, Woo Chul Noh, Min-Ki Seong, Seung-Sook Lee, Byung Il Kim, Chang Woon Choi, Sang Moo Lim, Sang-Keun Woo Scientific Reports.2020;[Epub] CrossRef
Patterns of Regression in Breast Cancer after Primary Systemic Treatment Tamás Zombori, Gábor Cserni Pathology & Oncology Research.2019; 25(3): 1153. CrossRef
The Role of Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio in Predicting Neoadjuvant Chemotherapy Response in Breast Cancer Hee Yeon Kim, Tae Hyun Kim, Hye Kyoung Yoon, Anbok Lee Journal of Breast Cancer.2019; 22(3): 425. CrossRef
Higher underestimation of tumour size post-neoadjuvant chemotherapy with breast magnetic resonance imaging (MRI)—A concordance comparison cohort analysis Wen-Pei Wu, Hwa-Koon Wu, Chih-Jung Chen, Chih-Wie Lee, Shou-Tung Chen, Dar-Ren Chen, Chen-Te Chou, Chi Wei Mok, Hung-Wen Lai, Pascal A. T. Baltzer PLOS ONE.2019; 14(10): e0222917. CrossRef
Multimodal image-guided surgery of HER2-positive breast cancer using [111In]In-DTPA-trastuzumab-IRDye800CW in an orthotopic breast tumor model Marion M. Deken, Desirée L. Bos, Willemieke S. F. J. Tummers, Taryn L. March, Cornelis J. H. van de Velde, Mark Rijpkema, Alexander L. Vahrmeijer EJNMMI Research.2019;[Epub] CrossRef
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer Ida Skarping, Daniel Förnvik, Hanna Sartor, Uffe Heide-Jørgensen, Sophia Zackrisson, Signe Borgquist BMC Cancer.2019;[Epub] CrossRef
ALDH1 and tumor infiltrating lymphocytes as predictors for neoadjuvant chemotherapy response in breast cancer Anbok Lee, Kyu Yeoun Won, Sung-Jig Lim, Sun Young Cho, Sang-Ah Han, SaeGwang Park, Jeong-Yoon Song Pathology - Research and Practice.2018; 214(5): 619. CrossRef
Early Prediction of Response to Neoadjuvant Chemotherapy Using Dynamic Contrast-Enhanced MRI and Ultrasound in Breast Cancer Yunju Kim, Sung Hun Kim, Byung Joo Song, Bong Joo Kang, Kwang-il Yim, Ahwon Lee, Yoonho Nam Korean Journal of Radiology.2018; 19(4): 682. CrossRef
Outcomes of neoadjuvant and adjuvant chemotherapy in stage 2 and 3 non-small cell lung cancer: an analysis of the National Cancer Database Matthew MacLean, Xin Luo, Shidan Wang, Kemp Kernstine, David E. Gerber, Yang Xie Oncotarget.2018; 9(36): 24470. CrossRef
Automatic cellularity assessment from post‐treated breast surgical specimens Mohammad Peikari, Sherine Salama, Sharon Nofech‐Mozes, Anne L. Martel Cytometry Part A.2017; 91(11): 1078. CrossRef
The importance of tissue confirmation of metastatic disease in patients with breast cancer: lesson from a brain metastasis case Jingxian Ding, Pinghua Hu, Jun Chen, Xiaobo Wu, Yali Cao Oncoscience.2016; 3(9-10): 268. CrossRef